PT

Dados B3 › Restatements

Has CIA. DISTRIB. DE GÁS DO RIO DE JANEIRO (CEGR3) ever restated its financial statements? In which years?

Yes: the statements for 2010, 2014, 2015, 2017 came back with different figures in the following year's annual filing — 10 account(s) in all, each below with both values.

YearAccountAs first filedAs restatedDifferenceRevealed in (CVM file)
2010gross profit (DRE 3.03)R$ 732.8 mR$ 674.6 m7.9%DFP 2011 · 28/03/2012
2010cost of goods and services (DRE 3.02)R$ -1.53 bnR$ -1.59 bn3.7%DFP 2011 · 28/03/2012
2010current assets (BPA 1.01)R$ 420.6 mR$ 417.4 m0.8%DFP 2011 · 28/03/2012
2014net operating cash flow (DFC_MI 6.01)R$ 465.1 mR$ 368.4 m20.8%DFP 2015 · 27/04/2016
2014gross profit (DRE 3.03)R$ 940.1 mR$ 922.2 m1.9%DFP 2015 · 27/04/2016
2014cost of goods and services (DRE 3.02)R$ -2.58 bnR$ -2.60 bn0.7%DFP 2015 · 27/04/2016
2015gross profit (DRE 3.03)R$ 927.2 mR$ 866.1 m6.6%DFP 2016 · 28/03/2017
2015cost of goods and services (DRE 3.02)R$ -2.80 bnR$ -2.86 bn2.1%DFP 2016 · 28/03/2017
2017financial investments (BPA 1.01.02)R$ 0 kR$ 41.9 m100.0%DFP 2018 · 25/03/2019
2017cash and equivalents (BPA 1.01.01)R$ 74.6 mR$ 32.8 m56.1%DFP 2018 · 25/03/2019

How it is detected: each year appears twice at the CVM — in its own annual filing and as the comparative in the next one. A difference above 0.5% in a key account is recorded, never corrected silently. Only the aggregation the site publishes (consolidated, or individual when the company does not consolidate) counts. Descriptive, not investment advice.

CEGR3 — company page · all restatements in the base

Numbers on this page are live. Data version 2026-09-24-salto-de-acoes · page generated 2026-09-26 23:57 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-09-24-salto-de-acoes · page generated 2026-09-26 23:57 UTC. If this does not match /saude, you are reading a cached copy.